Clinical characteristics, patterns of lipid-lowering medication use, and health care resource utilization and costs among patients with atherosclerotic cardiovascular disease

Clinical characteristics, patterns of lipid-lowering medication use, and health care resource utilization and costs among patients with atherosclerotic cardiovascular disease

Thomas P Power,1 Xuehua Ke,2 Zhenxiang Zhao,3 Nicole Gidaya Bonine,2 Mark J Cziraky,2 Michael Grabner,2 John J Barron,2 Ralph Quimbo,2 Burkhard Vangerow,3 Peter P Toth4,5 1AIM Specialty Health, Chicago, IL, 2HealthCore, Inc., Wilmington, DE, 3Eli Lilly and Company, Indianapolis, IN, 4CGH Medical Cen...

Full description

Bibliographic Details
Main Authors:	Power TP, Ke X, Zhao Z, Bonine NG, Cziraky MJ, Grabner M, Barron JJ, Quimbo R, Vangerow B, Toth PP
Format:	Article
Language:	English
Published:	Dove Medical Press 2018-02-01
Series:	Vascular Health and Risk Management
Subjects:	ASCVD low-density lipoprotein cholesterol lipid-lowering medications healthcare resource utilization and costs statins treatment patterns guidelines real-world evidence
Online Access:	https://www.dovepress.com/clinical-characteristics-patterns-of-lipid-lowering-medication-use-and-peer-reviewed-article-VHRM

Similar Items

A simplified approach to identification of risk status in patients with atherosclerotic cardiovascular disease
by: Aparna Sajja, MD, et al.
Published: (2021-09-01)

Low-density lipoprotein cholesterol outcomes post-non-PCSK9i lipid-lowering therapies in atherosclerotic cardiovascular disease and probable heterozygous familial hypercholesterolemia patients
by: Chen CC, et al.
Published: (2018-12-01)

Forty‐eight weeks of statin therapy for type 2 diabetes mellitus patients with lower extremity atherosclerotic disease: Comparison of the effects of pitavastatin and atorvastatin on lower femoral total plaque areas
by: Xieda Zhou, et al.
Published: (2021-07-01)

Implications of the 2013 ACC/AHA cholesterol guidelines on contemporary clinical practice for patients with atherosclerotic coronary and peripheral arterial disease
by: Prasad Gunasekaran, et al.
Published: (2017-07-01)

Comparative study of low density lipoprotein by estimation and calculation from lipid profile in a tertiary hospital
by: Lavanya Lagisetty, et al.
Published: (2020-01-01)

Same evidence, varying viewpoints: Three questions illustrating important differences between United States and European cholesterol guideline recommendations
by: David I. Feldman, et al.
Published: (2020-12-01)

From intensive statins to intensive lipid lowering: Amplitude of low-density lipoprotein-cholesterol lowering is the core for atherosclerosis cardiovascular disease prevention
by: Daoquan Peng
Published: (2018-01-01)

LDL Cholesterol, Statins And PCSK 9 Inhibitors
by: Sanjiv Gupta
Published: (2015-09-01)

Lipid Control Post Coronary Artery Bypass Graft: One Year Follow-Up of a Middle-Eastern Cohort
by: Bassam Atallah, et al.
Published: (2020-02-01)

Plasma Aldosterone Concentration as a Determinant for Statin Use among Middle-Aged Hypertensive Patients for Atherosclerotic Cardiovascular Disease
by: Jui-Hsiang Lin, et al.
Published: (2018-10-01)

Non-high-density lipoprotein (non-HDL) cholesterol in adolescence as a predictor of atherosclerotic cardiovascular diseases in adulthood
by: Saeed Shoar, et al.
Published: (2021-06-01)

Guideline Concordance of Statin Treatment Decisions: A Retrospective Cohort Study
by: Yael Rachamin, et al.
Published: (2020-11-01)

Angiopoietin-Like Protein 3 (ANGPTL3) Modulates Lipoprotein Metabolism and Dyslipidemia
by: Pei-Yi Chen, et al.
Published: (2021-07-01)

Treatment patterns and patient characteristics among early initiators of PCSK9 inhibitors
by: Hines DM, et al.
Published: (2018-12-01)

Knowns and unknowns in the care of pediatric familial hypercholesterolemia
by: Andrew C. Martin, et al.
Published: (2017-09-01)

Familial hypercholesterolemia: current status of the problem, treatment, and prevention
by: S. A. Bliznyuk, et al.
Published: (2020-11-01)

Low-Density Lipoprotein Cholesterol Treatment Rates in High Risk Patients: More Disappointment Despite Ever More Refined Evidence-Based Guidelines.
by: Peter P. Toth, MD, PhD
Published: (2021-06-01)

Association of cardiovascular risk profile with healthcare expenditure and resource utilization in chronic obstructive pulmonary disease, with and without atherosclerotic cardiovascular disease
by: Zain Jafar, et al.
Published: (2020-09-01)

Risk of Recurrent Coronary Events in Patients With Familial Hypercholesterolemia; A 10-Years Prospective Study
by: Kjell-Erik Arnesen, et al.
Published: (2021-03-01)

Preventive cardiology as a dedicated clinical service: The past, the present, and the (Magnificent) future
by: Michael D. Shapiro, et al.
Published: (2020-03-01)

Comparison between clinic and home measurements of blood pressure, total cholesterol, blood sugar to identify 10-year atherosclerotic cardiovascular disease risk score
by: Putri Ani Sunjaya, et al.
Published: (2021-03-01)

Lipid Testing Trends in the US Before and After the Release of the 2013 Cholesterol Treatment Guidelines
by: Levintow SN, et al.
Published: (2020-08-01)

Cholesterol-Lowering Drugs on Akt Signaling for Prevention of Tumorigenesis
by: Navneet Kumar, et al.
Published: (2021-09-01)

Eligibility for Statin Treatment in Korean Subjects with Reduced Renal Function: An Observational Study
by: Byung Sub Moon, et al.
Published: (2016-09-01)

Impact of China’s Low Centralized Medicine Procurement Prices on the Cost-Effectiveness of Statins for the Primary Prevention of Atherosclerotic Cardiovascular Disease
by: Miao Wang, et al.
Published: (2020-06-01)

New perspectives in treating high-risk cardiac patients. Rosuvastain and it’s perspectives for clinical practice use
by: M. G. Bubnova
Published: (2007-12-01)

Suboptimal control of lipid levels: results from the non-interventional Centralized Pan-Russian Survey of the Undertreatment of Hypercholesterolemia II (CEPHEUS II)
by: Sergey Boytsov, et al.
Published: (2017-12-01)

Serum lipids and smoking status in coronary heart disease patients treated with simvastatin
by: L. R. Gazdanova, et al.
Published: (2010-04-01)

Efficacy of Combination Therapy of Rosuvastatin and Ezetimibe vs Rosuvastatin Monotherapy on Lipid Profile of Patients with Coronary Artery Disease
by: Sandeep Joshi, et al.
Published: (2017-12-01)

Response by sex to statin plus ezetimibe or statin monotherapy: A pooled analysis of 22,231 hyperlipidemic patients
by: Lin Jianxin, et al.
Published: (2011-08-01)

High-intensity therapy: rationale, indications and safety issues. Prospects of rosuvastatin in clinical practice
by: M. G Bubnova
Published: (2017-12-01)

Lipid treatment and goal attainment characteristics among persons with atherosclerotic cardiovascular disease in the United States
by: Alexa C. Klimchak, et al.
Published: (2020-03-01)

Prevalence of dyslipidemia in statin-treated patients in the Baltic states (Estonia, Latvia, and Lithuania): Results of the Dyslipidemia International Study (DYSIS)
by: Margus Viigimaa, et al.
Published: (2014-01-01)

Levels of atherogenic lipoproteins are unexpectedly reduced in interstitial fluid from type 2 diabetes patients[S]
by: Johanna Apro, et al.
Published: (2015-08-01)

Prevalence and associated factors of uncontrolled hyperlipidemia among Thai patients with diabetes and clinical atherosclerotic cardiovascular diseases: a cross-sectional study
by: Teeraboon Lertwanichwattana, et al.
Published: (2021-03-01)

Development and validation of a polysocial risk score for atherosclerotic cardiovascular disease
by: Zulqarnain Javed, et al.
Published: (2021-12-01)

Heterogeneity in cardio-metabolic risk factors and atherosclerotic cardiovascular disease among Asian groups in the United States
by: Priyanka Satish, et al.
Published: (2021-09-01)

Chinese ASCVD risk equations rather than pooled cohort equations are better to identify macro- and microcirculation abnormalities
by: Qiaowei Li, et al.
Published: (2020-03-01)

Familial Hypercholesterolemia: New Horizons for Diagnosis and Effective Management
by: Maria Mytilinaiou, et al.
Published: (2018-07-01)

Evaluation of statin use on LDL cholesterol levels in Turkey: A systematic review
by: Pınar Kızılırmak, et al.
Published: (2020-03-01)